Fundraising Fox
Betherapeutics
Founded 2023 · 5 employees on LinkedIn · 2 known investors
Find your way into Betherapeutics
Sign up to find every way you can get introduced to Betherapeutics
- Your email: who you already know at Betherapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Betherapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
Founders & leadership
P
PhilipChief Scientific Officer
Investors · 2
Frequently asked questions
- What does Betherapeutics do?
- BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
- Who are Betherapeutics's investors?
- Betherapeutics's investors include Alumni Ventures, Moonstone Venture Capital.